Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines SL Demento, AL Siefert, A Bandyopadhyay, FA Sharp, TM Fahmy Trends in biotechnology 29 (6), 294-306, 2011 | 202 | 2011 |
Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy KD Srivastava, A Siefert, TM Fahmy, MJ Caplan, XM Li, HA Sampson Journal of Allergy and Clinical Immunology 138 (2), 536-543. e4, 2016 | 102 | 2016 |
Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy AL Siefert, MJ Caplan, TM Fahmy Biomaterials 97, 85-96, 2016 | 75 | 2016 |
Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA S Zeller, CS Choi, PD Uchil, HS Ban, A Siefert, TM Fahmy, W Mothes, ... Chemistry & biology 22 (1), 50-62, 2015 | 45 | 2015 |
Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin JS Lee, P Han, R Chaudhury, S Khan, S Bickerton, MD McHugh, HB Park, ... Nature Biomedical Engineering 5 (9), 983-997, 2021 | 36 | 2021 |
Cell-specific siRNA delivery by peptides and antibodies SK Lee, A Siefert, J Beloor, TM Fahmy, P Kumar Methods in Enzymology 502, 91-122, 2012 | 31 | 2012 |
Immunomodulatory nanoparticles ameliorate disease in the Leishmania (Viannia) panamensis mouse model AL Siefert, A Ehrlich, MJ Corral, K Goldsmith-Pestana, D McMahon-Pratt, ... Biomaterials 108, 168-176, 2016 | 19 | 2016 |
The Yale Center for Biomedical Innovation and Technology (CBIT): one model to accelerate impact from academic health care innovation AL Siefert, MS Cartiera, AN Khalid, MC Nantel, CR Loose, PG Schulam, ... Academic Medicine 94 (4), 528-534, 2019 | 18 | 2019 |
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents TM Fahmy, E Stern, RA Flavell, J Park, A Siefert, SH Wrzesinski US Patent 9,610,250, 2017 | 16 | 2017 |
Skills beyond the Reading room: training in innovation and collaboration at a radiology hackathon K Cooper, A Siefert, J Weinreb Journal of the American College of Radiology 15 (3), 466-468, 2018 | 12 | 2018 |
Artificial antigen-presenting cells for immunotherapies AL Siefert, TM Fahmy, D Kim Cancer Nanotechnology: Methods and Protocols, 343-353, 2017 | 10 | 2017 |
Investigation of peanut oral immunotherapy using CpG/peanut-nanoparticles in a murine model of peanut allergy KD Srivastava, A Siefert, T Fahmy, MJ Caplan, XM Li, HA Sampson Journal of Allergy and Clinical Immunology 135 (2), AB235, 2015 | 5 | 2015 |
An integrated undergraduate biomedical engineering laboratory course C Zapanta, W Ruder, J Newberg, P Glass, D Minhas, EG Osuna, LT Sun, ... 2009 Annual Conference & Exposition, 14.200. 1-14.200. 32, 2009 | 5 | 2009 |
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents TM Fahmy, E Stern, RA Flavell, J Park, A Siefert, SH Wrzesinski US Patent 10,603,276, 2020 | 4 | 2020 |
Yale CBIT: Catalyzing biomedical innovation M Cartiera, A Siefert | 1 | 2016 |
Biomimetic Nanosystems Targeting Antigen-Presenting Cells for Improved Immunotherapeutics AL Siefert Yale University, 2015 | 1 | 2015 |
Yale Center for Biomedical and Interventional Technology (CBIT) A Siefert, J Zinter, P Schulam, C Loose, A Khalid, M Dempsey, J Zheng, ... IJAMM, 2023 | | 2023 |
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents TM Fahmy, E Stern, RA Flavell, J Park, A Siefert, SH Wrzesinski US Patent App. 17/399,544, 2022 | | 2022 |
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents TM Fahmy, E Stern, RA Flavell, J Park, A Siefert, SH Wrzesinski US Patent 11,173,119, 2021 | | 2021 |
Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin (vol 5, pg 983, 2021) JS Lee, P Han, R Chaudhury, S Khan, S Bickerton, MD McHugh, HB Park, ... NATURE BIOMEDICAL ENGINEERING 5 (11), 1403-1403, 2021 | | 2021 |